Kiara Health (Pty) Ltd is proud to have been chosen as the partner, in select SSA markets, to Shin Poong Pharmaceutical Co. Ltd., South Korea, for the marketing and distribution of their WHO prequalified artesunate-pyronaridine (AS-PY) fixed-dose antimalarial combination, co-developed with Medicines for Malaria Venture (MMV).
The MMV and Shin Poong fixed-dose combination, is the newest and only artemisinin-based combination therapy (ACT) to be granted a positive scientific opinion under the Article 58 procedure of the European Medicines Agency (EMA). It is also the only ACT to be registered by a stringent regulatory authority for the blood-stage treatment of both the two main strains of malaria: P. falciparum and P. vivax. The WHO recommends ACTs as first- and second-line treatment for uncomplicated malaria caused by P. falciparum.
The MMV and Shin Poong artesunate-pyronaridine (AS-PY) fixed-dose combination is available as granules, for the treatment of uncomplicated malaria in children from 5 – 20 kg, and was added to the World Health Organization’s (WHO) list of prequalified medicines in March 2016 and to the WHO Essential Medicines List for Children (EMLc) in 2017. Additionally, the MMV and Shin Poong artesunate-pyronaridine (AS-PY) tablets, for the treatment of uncomplicated malaria in adolescents and adult above 20kg, was added to the World Health Organization’s (WHO) list of prequalified medicines in 2012 and to the WHO Essential Medicines List for Adults (EML) in 2017.
Kiara Health is an African pharmaceutical manufacturing and healthcare solutions company headquartered in Johannesburg, South Africa. It serves as the local, non-exclusive manufacturing partner for a Global Top 5 pharmaceutical company and as a commercial partner for several global pharmaceutical and medical technology companies. With its alliance to Imperial, a Top 30 Global Logistics company, Kiara Health has access to over 800 million patient lives across SSA. Says Dr Skhumbuzo Ngozwana, President and CEO, “At Kiara Health, we are steadfast in our vision of progressing African healthcare. Our mission is to restore, preserve and advance the health of all patients, particularly those on the African continent, by providing world-class healthcare solutions. We firmly believe that our partnership with Shin Poong fosters this mission to achieve our mission.”
